Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Coherus BioSciences Inc banner

Coherus BioSciences Inc
NASDAQ:CHRS

Watchlist Manager
Coherus BioSciences Inc Logo
Coherus BioSciences Inc
NASDAQ:CHRS
Watchlist
Price: 1.66 USD 1.22% Market Closed
Market Cap: $248.8m
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall St Price Targets

CHRS Price Targets Summary
Coherus BioSciences Inc

Wall Street analysts forecast CHRS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CHRS is 5.78 USD with a low forecast of 4.04 USD and a high forecast of 7.35 USD.

CHRS Lowest Forecast
4.04 USD
143% Upside
CHRS Average Forecast
5.78 USD
248% Upside
CHRS Highest Forecast
7.35 USD
343% Upside
Lowest Forecast
Price Target
4.04 USD
143% Upside
Average Forecast
Price Target
5.78 USD
248% Upside
Highest Forecast
Price Target
7.35 USD
343% Upside
Coherus BioSciences Inc Competitors:
Price Targets
EBMT
Eagle Bancorp Montana Inc
2% Upside
AREC
American Resources Corp
165% Upside
AFYA
Afya Ltd
23% Upside
V
VERK
Verkkokauppa.com Oyj
20% Upside
EBMT
Eagle Bancorp Montana Inc
2% Upside
AREC
American Resources Corp
165% Upside
AFYA
Afya Ltd
23% Upside
V
VERK
Verkkokauppa.com Oyj
20% Upside

Revenue
Forecast

25% / Year
Past Growth
46% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
25% / Year
Past Growth
46% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Over the last 12 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 8 years is 46%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-58%
Average Miss
N/A
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-58%
Average Miss

The compound annual growth rate for Net Income over the next 8 years is 6%.

What are analyst estimates?

See Also

Summary
CHRS intrinsic value, competitors valuation, and company profile.
DCF Valuation
CHRS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CHRS stock valuation using valuation multiples.
Wall St Estimates
CHRS price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CHRS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Coherus BioSciences Inc listings:
F • EUR
8C5
 SWB • EUR
8C5
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CHRS's stock price target?
Price Target
5.78 USD

According to Wall Street analysts, the average 1-year price target for CHRS is 5.78 USD with a low forecast of 4.04 USD and a high forecast of 7.35 USD.

What is the Revenue forecast for Coherus BioSciences Inc?
Projected CAGR
46%

Over the last 12 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 8 years is 46%.

What is the Net Income forecast for Coherus BioSciences Inc?
Projected CAGR
6%

The compound annual growth rate for Net Income over the next 8 years is 6%.

Back to Top
ALPHA SPREAD
Follow us
Join 340,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett